Learn more

CERENO SCIENT AB

Overview
  • Total Patents
    45
  • GoodIP Patent Rank
    38,468
  • Filing trend
    ⇩ 80.0%
About

CERENO SCIENT AB has a total of 45 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2012. It filed its patents most often in United Kingdom, United States and Australia. Its main competitors in its focus markets pharmaceuticals and measurement are EYE THERAPIES LLC, CRAUN RES SDN BHD and BIGNOTTI ANDREA.

Patent filings per year

Chart showing CERENO SCIENT ABs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Jern Sverker 28
#2 Bergh Niklas 28
#3 Saljo Jonas Faijerson 13
#4 Gustafsson Nils Ove 8
#5 Larsson Pia 8
#6 Säljö Jonas Faijerson 7
#7 Niklas Bergh 5
#8 Sverker Jern 5
#9 Martensson Hans Roger Marcus 4
#10 Mårtensson Hans Roger Marcus 3

Latest patents

Publication Filing date Title
GB202002006D0 Compositions comprising histone deacetylase inhibiting compounds, and uses thereof
GB202001871D0 Compositions comprising histone deacetylase inhibiting compounds, and uses thereof
GB202001867D0 Compositions comprising histone deacetylase inhibiting compounds, and uses thereof
GB202001869D0 New compounds
GB202001868D0 Compositions comprising histone deacetylase inhibiting compounds, and uses thereof
GB201907398D0 Deuterated valproic acid analogues
GB201906286D0 Deuterated valproic acid analogues
GB201816605D0 New formulations and uses thereof
GB201716745D0 New formulations and uses thereof
KR20180127480A Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof
US2020179381A1 Compounds and compositions for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation
GB201417828D0 New methods and compositions
CN103648492A Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors